Stocks · Healthcare · Medical - Devices
AxoGen, Inc. AXGN
$37.22 -0.45% Close, Oct 5, 2026 · NASDAQ · Market cap $2.01B
High quality
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The diluted share count rose 17.0% in a year.
- Over the past year the stock returned +108.2%, ahead of the S&P 500 by 92.4 percentage points.
- Revenue over the last four quarters was $251.2M, up 23.6% from a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
Growth60Neutral
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 30%
- FCF growth (TTM, YoY)Bottom 20%
- Revenue growth, 3-year CAGRTop 35%
- Revenue growth accelerationTop 35%
Quality82Strong
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 37%
- Gross marginTop 37%
- Operating marginTop 48%
- Accruals (lower is better)Top 24%
- Interest coverTop 47%
Value60Neutral
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 35%
- Free-cash-flow yieldTop 35%
- EBITDA / enterprise valueTop 40%
- Sales / enterprise valueBottom 36%
Momentum67Positive
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 9%
- 6-month returnTop 44%
- 1-year return vs S&P 500Top 15%
- Distance from 52-week highTop 47%
- Trend checklist (0–4)Bottom 36%
Revisions23Very weak
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 31%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 35%
- Upside to consensus price targetBottom 42%
Stability69Positive
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 42%
- Maximum drawdown, 3 yearsTop 27%
- Beta vs S&P 500 (lower is better)Top 46%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 22.4% | 23.6% | ↑ |
| Gross margin | 74.3% | 74.6% | ↑ |
| Operating margin | 0.8% | -5.1% | ↓ |
| FCF margin | 2.1% | 1.0% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 23.6% | 22.4% | ↑ | Top 30% |
| Gross margin | 74.6% | 74.3% | ↑ | Top 37% |
| Operating margin | -5.1% | 0.8% | ↓ | Top 48% |
| Net margin | -13.4% | -2.3% | ↓ | — |
| Free-cash-flow margin | 1.0% | 2.1% | ↓ | — |
| Return on invested capital | -4.6% | — | Top 37% | |
| Revenue growth, 3-year CAGR | 17.6% | — | Top 35% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -14.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 15.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -1.8 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -1.0×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -7.02%
- Shareholder yield
- -7.02%
- Share count change, 1 year
- +17.0%
- Share count change, 3-year CAGR
- +7.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 29, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- -7.7%
- Average 2-day reaction, last 8
- +0.8%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $52.80
- Target vs current price
- +41.9%
- Analysts with a rating
- 20
- Share rating Buy or Strong Buy
- 85%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 29, 2026 | -1.2% | +0.5% | +11.7% | +21.3% | — |
| Apr 28, 2026 | -41.7% | +6.6% | +8.2% | +5.2% | +0.9% |
| Feb 24, 2026 | -21.2% | -8.1% | -13.4% | -10.3% | +20.7% |
| Oct 29, 2025 | +33.3% | +23.1% | +31.5% | +56.6% | +92.0% |
| Aug 5, 2025 | +100.0% | +9.3% | +11.6% | +25.2% | +44.1% |
| May 8, 2025 | -100.0% | -23.2% | -27.9% | -34.1% | -23.4% |
| Feb 25, 2025 | +100.0% | +11.7% | +7.1% | +0.8% | -35.8% |
| Nov 7, 2024 | +1066.7% | -13.4% | -18.2% | -4.3% | +23.2% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | $0.12 | $0.12 | -1.2% | $69.7M |
| Apr 28, 2026 | $0.07 | $0.12 | -41.7% | $61.5M |
| Feb 24, 2026 | $0.07 | $0.09 | -21.2% | $59.9M |
| Oct 29, 2025 | $0.12 | $0.09 | +33.3% | $60.1M |
| Aug 5, 2025 | $0.12 | $0.06 | +100.0% | $56.7M |
| May 8, 2025 | -$0.02 | -$0.01 | -100.0% | $48.6M |
| Feb 25, 2025 | $0.08 | $0.04 | +100.0% | $49.4M |
| Nov 7, 2024 | $0.07 | $0.01 | +1066.7% | $48.6M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 84.1× | — | — | — |
| EV / Sales | 7.71× | — | — | Bottom 36% |
| Free-cash-flow yield | 0.13% | — | — | Top 35% |
| Earnings yield | -1.82% | — | — | Top 35% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +1.2%
- 200-day average slope (20 days)
- +3.8%
- Distance from 50-day average
- -18.6%
- Distance from 200-day average
- -4.5%
- RSI (14)
- 27.2
- Relative volume
- 1.43×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 51.5%
- Volatility vs own 5-year history
- 25th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.04
- Correlation with S&P 500
- 0.27
- Current drawdown from 1-year high
- -28.0%
- Maximum drawdown, 3 years
- -53.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| May 7, 2021 | Nov 1, 2023 | -84.6% | 626 days | 503 days (Nov 4, 2025) |
| Aug 27, 2026 | Oct 5, 2026 | -28.1% | 26 days | Not yet recovered |
| Mar 1, 2021 | Apr 19, 2021 | -21.2% | 34 days | 14 days (May 7, 2021) |
| Feb 23, 2026 | Mar 6, 2026 | -19.3% | 9 days | 28 days (Apr 16, 2026) |
| Jun 30, 2026 | Jul 15, 2026 | -16.2% | 10 days | 17 days (Aug 7, 2026) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $2.01B
- EPS, diluted (TTM)
- -$0.68
- Revenue (TTM)
- $251.2M
- 52-week range
- $15.27 – $52.91
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $127.4M | $138.6M | $159.0M | $187.3M | $225.2M |
| Gross profit | $104.4M | $108.8M | $121.9M | $142.0M | $167.4M |
| Operating income | -$25.4M | -$29.7M | -$21.5M | -$3.3M | -$7.8M |
| Net income | -$27.0M | -$28.9M | -$21.7M | -$10.0M | -$15.7M |
| EPS (diluted) | -$0.65 | -$0.69 | -$0.51 | -$0.23 | -$0.34 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $48.6M | $49.4M | $48.6M | $56.7M | $60.1M | $59.9M | $61.5M | $69.7M |
| Net income | -$1.9M | $450,000 | -$3.8M | $579,000 | $708,000 | -$13.2M | -$19.6M | -$1.5M |
| EPS (diluted) | -$0.04 | $0.01 | -$0.08 | $0.01 | $0.01 | -$0.28 | -$0.38 | -$0.03 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$13.4M | -$16.1M | -$5.7M | $4.5M | $812,000 |
| Capital expenditure | -$28.4M | -$21.3M | -$14.9M | -$4.5M | -$3.7M |
| Free cash flow | -$41.8M | -$37.3M | -$20.6M | $11,000 | -$2.9M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $5.5M | $1.8M | $2.0M | $2.3M | $10.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $94.6M
- Total assets
- $304.9M
- Total liabilities
- $48.6M
- Total debt
- $20.1M
- Net debt
- -$74.5M
- Shareholders’ equity
- $256.3M
As of Jun 30, 2026 (filed Jul 29, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Jan 27, 2010 | $1.00 | Feb 12, 2010 |
| Feb 23, 2005 | $0.06 | — |
| Jul 10, 1992 | $0.04 | — |
Short interest
- Shares sold short
- 4,055,417
- Days to cover
- 2.86
- Change vs previous report
- +6.5%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jul 11, 1994
- 21-for-20
- Jul 12, 1993
- 21-for-20
- Jul 10, 1992
- 21-for-20